New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. - Test2 - elhamkhani - TriplyDB

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

http://www.wikidata.org/entity/Q34515911

about

KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1 Recent advances in subtyping tumors of the central nervous system using molecular data.Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.MethPed: an R package for the identification of pediatric brain tumor subtypes Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway.Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.Quantifying the number of independent organelle DNA insertions in genome evolution and human health.Milestones of the last 10 years: CNS cancer Head and Neck Round Cell Sarcomas: A Comparative Clinicopathologic Analysis of 2 Molecular Subsets: Ewing and CIC-Rearranged Sarcomas.Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements.Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.Molecular pathology of paediatric central nervous system tumours.Low-grade epilepsy-associated neuroepithelial tumours - the 2016 WHO classification.The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.Modeling and Targeting MYC Genes in Childhood Brain Tumors.Integrating RNA sequencing into neuro-oncology practice.CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study.Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.The 2016 World Health Organization Classification of tumours of the Central Nervous System: what the paediatric neuroradiologist needs to know Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies.Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.A double-edged sword: The world according to Capicua in cancer.BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data.Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter-hypermethylation - the NCT Neuro Master Match (N2M2) pilot study.

P2860

Q27727752-B5685DF7-5EC4-43E1-AF4B-7918F95D2BD4 Q31145092-B61A568A-4A44-45C0-AA17-C118D2A79537 Q31151075-400D4C8E-8E11-4356-95DB-E66EDCC02338 Q33276475-F333B5D7-721D-48B1-BDD8-CE667CD39A77 Q36066534-933D2373-51A3-4505-9B73-E2A1F24DE743 Q36293972-E148826D-FCC4-4D95-8C22-D4460722F2F4 Q37666306-149C5F28-9DF7-4AC7-A346-4C627A0DF675 Q37706929-82F1C92D-50B5-4A49-9448-2AE1C71C3AEB Q38372849-F1A8CFC0-DBCF-457A-AED3-7E78D2B99AE7 Q38633637-B3D370BF-013D-46E0-AD39-2058B92CB611 Q38686509-40564592-9F54-4856-AA4B-870EEBEE8D96 Q38817788-F6375206-006F-44E1-86F5-9A1BF91312C6 Q38819210-891A2F7C-6DB1-48DE-A4A1-B8FB93DF8D34 Q38861548-1A50D96B-D3BF-411D-BD64-0EC898E88896 Q38880567-B68B7B15-0213-417B-830B-8CA4AE9CA471 Q38889086-C709DDF9-E085-48A5-B1C5-0DD39DF4F4B4 Q38944659-6F984DA5-234F-48AE-9C1C-30FE42C4FD4A Q38955101-BF127646-F3EC-4E0B-A272-02F00CA6A2FF Q38971961-9043A68B-BF99-4777-837A-BB20CF394F80 Q39011462-617170AD-6AA8-4BC1-A7FD-A2063851CA10 Q39091307-459447E1-B781-4F0E-9980-6F17E6FEC9BD Q39094276-E7BF71ED-615D-4245-8B8A-F4E4D6A04D45 Q39195507-7EC2C419-1711-4FCA-8862-BFC1DADA9342 Q39459649-4A434301-45C9-4082-AFC9-D269B30EB222 Q40217307-FD9990CE-10B5-4E70-8682-CF79FD4DFBB8 Q40483871-5D6D77A4-ADFC-4705-8C79-AFAB5A91B0B2 Q41485878-2DA6BA50-5B8E-4E45-9E40-1E6BB107F00C Q42361001-5179299D-E265-44D7-957D-C22079C68ECB Q42362675-D5CA3268-1422-4DC3-8B04-4D1DC08713DB Q42503619-E036BDCB-5D0C-4EFC-A1CE-4A5930C6DA71 Q45156423-C23C3E56-8A3F-432B-B578-46197D82D5D1 Q45936711-929D0359-BF0B-454D-806B-B857171E7C51 Q46001867-EC48BB13-C910-4FF1-8ACA-FD2BAB785A28 Q47098092-4AF42B65-CA1C-4864-89E7-94AEC7881FD1 Q47114454-02CBBEFF-8C32-49E8-A7EA-FEFC585FD9FB Q47210871-51ACA90C-D080-4F81-954B-5C334490D10E Q47211556-2E5EC961-5388-483E-8A1F-C2913BAE803B Q47296254-DA6AD077-A4D5-42E2-AF5B-13940AF2A702 Q47308816-18BEFE7F-036A-412B-820C-1ECB7D73641B Q47374036-0DD83EB7-E365-4762-A715-085F7375A39D

P2860

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

http://www.wikidata.org/entity/Q34515911

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@ast

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@en

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@nl

type

label

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@ast

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@en

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@nl

prefLabel

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@ast

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@en

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@nl

P1433

Q34515911-1F73CFEE-13DF-4138-8B5D-270BF24968A6

P1476

Q34515911-07A8DB68-B475-4766-A62E-8BB67427D6AB

P2093

Q34515911-09BCF8F1-2BE5-4E4E-A230-8B525DAFC738

Q34515911-0CB3E1FE-6C56-468B-938C-A8A334DC1899

Q34515911-0D989E10-63DD-4F3F-A488-E307B66D5473

Q34515911-0E3DDDF0-5420-467A-AED5-008E16CBC7F3

Q34515911-16EE43B4-FF84-4507-AAFB-FFF4EAD39EE8

Q34515911-1997112A-046B-44B7-9777-49074D4D3DA2

Q34515911-1C7A8E66-5D0A-49E1-8896-DB62368A1FFB

Q34515911-1CC79EA1-5E29-46F2-9050-43E56AC23E87

Q34515911-219737BF-BCB1-4518-9C9C-F1F651AFAC1D

Q34515911-23F86ADE-5551-49B2-9833-029D53D64628

P2860

Q34515911-05E4F9FB-10BC-43AA-80A6-8111D78FC8E7

Q34515911-0D3E2A98-66E8-4271-9E31-4129502DEFBB

Q34515911-1A302554-B096-4ACA-999E-8146B71D4F51

Q34515911-1CE2F129-2469-4BA3-83AA-2A4C007CCDE2

Q34515911-280A43F9-C6DC-48A7-916D-54904169794D

Q34515911-2C171BE8-E150-4993-82F8-6AC4990C18C5

Q34515911-3FC3AD8D-D1A3-48C3-99EC-394D253AA4DA

Q34515911-40B403CF-BB4A-4530-8DF7-215827A7ABE8

Q34515911-47B9098A-E181-467A-AB4F-37DD793AB70B

Q34515911-4B865D59-70C3-4FC6-80B5-E4B202E4A553

P304

Q34515911-6D7BA1A4-990E-493B-96A8-1F50B1129DC8

P31

Q34515911-7B7ADE5D-FA84-4BCC-87C5-526DD2F2803A

P356

Q34515911-057F5EC8-A2BF-4695-9812-A251B01767EA

P407

Q34515911-9C054C6D-8B2D-47E7-BD9A-7D9DD628C0C1

P433

Q34515911-BEB5EC1A-3C5C-4382-BAF9-22E5E00B805B

P478

Q34515911-58DC70A8-E8B3-483C-8C37-6C40CA8DAEBE

P50

Q34515911-0E8D8051-97D9-4115-A72A-11861F5C2596

Q34515911-1CCA7511-AA43-489D-BAFB-05CA0E4257E5

Q34515911-1CEE7341-A420-4D83-B899-CE8140208ECE

Q34515911-2CA8983A-C952-4F3A-8628-98B6AD51D9FC

Q34515911-2D7C8168-6383-48ED-B251-E906C0945640

Q34515911-36F70A0E-6C8C-495B-A924-1193B6B42343

Q34515911-38032E23-1A38-4D72-AFD4-82C70DBC37CF

Q34515911-4254CC09-F37D-4309-9B88-91634BFAC841

Q34515911-49198F0A-E5B3-4CC7-91FF-42D3735DADE7

Q34515911-5650495C-C0DD-440D-88A9-CCF2A6A37888

P577

Q34515911-84B7C5D9-93F8-47E7-9D7E-232E96F7E37A

P5875

Q34515911-0C763FB4-C240-4A3E-8F98-5DDCC1D996CD

P698

Q34515911-7304DC33-AB5F-45A2-8FD7-3B5853E69C0F

P932

Q34515911-920AB72F-C22E-4380-BE97-7C1B4C7DEEC0

P356

J.CELL.2016.01.015

P1433

P1476

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

@en

P2093

Alan Mackay

http://www.w3.org/2001/XMLSchema#string

Amar Gajjar

http://www.w3.org/2001/XMLSchema#string

Andrey Korshunov

http://www.w3.org/2001/XMLSchema#string

André O von Bueren

http://www.w3.org/2001/XMLSchema#string

Anna M Buccoliero

http://www.w3.org/2001/XMLSchema#string

Anne Jouvet

http://www.w3.org/2001/XMLSchema#string

Arie Perry

http://www.w3.org/2001/XMLSchema#string

Barbara C Worst

http://www.w3.org/2001/XMLSchema#string

Brent A Orr

http://www.w3.org/2001/XMLSchema#string

Bret C Mobley

http://www.w3.org/2001/XMLSchema#string

P2860

Dissecting the genomic complexity underlying medulloblastoma

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

IDH1 and IDH2 mutations in gliomas

BEN: a novel domain in chromatin factors and DNA viral proteins

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

Integrative genomics viewer

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.

P304

1060-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2016.01.015

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Guido Reifenberger

Martin Hasselblatt

Stefan M Pfister

Dominique Figarella-Branger

Andreas von Deimling

Christel Herold-Mende

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296057154

http://www.w3.org/2001/XMLSchema#string

P698

26919435

http://www.w3.org/2001/XMLSchema#string

P932

5139621

http://www.w3.org/2001/XMLSchema#string